TNYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Tenaya Therapeutics Inc (TNYA) is not a good buy for a beginner, long-term investor at this time. The stock exhibits weak technical indicators, insider selling trends, poor financial performance, and lacks recent positive news or catalysts. Additionally, analyst ratings have been consistently lowering price targets, reflecting a cautious outlook. Given the user's investment profile and the lack of strong buy signals, it is best to hold off on investing in this stock.
The technical indicators for TNYA are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 34.65, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.567 and resistance at 0.697.
NULL. No recent news or events provide a strong positive catalyst for the stock.
Insiders are selling heavily, with a 55373.56% increase in selling activity over the last month. Financial performance is poor, with declining net income (-20.91% YoY) and EPS (-60.00% YoY). Analysts have consistently lowered price targets, citing dilution and cautious outlooks.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income drop of -20.91% YoY to -$20.28M, and a significant EPS decline of -60.00% YoY to -0.12. Gross margin remains at 0%.
Analysts have lowered price targets across the board: Morgan Stanley to $2, Canaccord to $4, Chardan to $8, and H.C. Wainwright to $3. While most maintain Buy or Overweight ratings, the consistent target reductions reflect a cautious outlook due to dilution and competitive pressures.
